NICE (NASDAQ: NICE) reported Q4 EPS of $2.36, $0.10 better than the analyst estimate of $2.26. Revenue for the quarter came in at $623.2 million versus the consensus estimate of $616.2 million.

GUIDANCE:

NICE sees Q1 2024 EPS of $2.40-$2.50, versus the consensus of $2.27. NICE sees Q1 2024 revenue of $650-660 million, versus the consensus of $640.7 million.

NICE sees FY2024 EPS of $10.40-$10.60, versus the consensus of $9.88. NICE sees FY2024 revenue of $2.71-2.73 billion, versus the consensus of $2.67 billion.

For earnings history and earnings-related data on NICE (NICE) click here.